Acceptability to patients, carers and clinicians of an mHealth platform for the management of Parkinson's disease (PD_Manager): study protocol for a pilot randomised controlled trial.

BACKGROUND: Parkinson's disease is a degenerative neurological condition causing multiple motor and non-motor symptoms that have a serious adverse effect on quality of life. Management is problematic due to the variable and fluctuating nature of symptoms, often hourly and daily. The PD_Manager mHealth platform aims to provide a continuous feed of data on symptoms to improve clinical understanding of the status of any individual patient and inform care planning. The objectives of this trial are to (1) assess patient (and family carer) perspectives of PD_Manager regarding comfort, acceptability and ease of use; (2) assess clinician views about the utility of the data generated by PD_Manager for clinical decision making and the acceptability of the system in clinical practice. METHODS/DESIGN: This trial is an unblinded, parallel, two-group, randomised controlled pilot study. A total of 200 persons with Parkinson's disease (Hoehn and Yahr stage 3, experiencing motor fluctuations at least 2 h per day), with primary family carers, in three countries (110 Rome, 50 Venice, Italy; 20 each in Ioannina, Greece and Surrey, England) will be recruited. Following informed consent, baseline information will be gathered, including the following: age, gender, education, attitudes to technology (patient and carer); time since Parkinson's diagnosis, symptom status and comorbidities (patient only). Randomisation will assign participants (1:1 in each country), to PD_Manager vs control, stratifying by age (1 ≤ 70 : 1 > 70) and gender (60% M: 40% F). The PD_Manager system captures continuous data on motor symptoms, sleep, activity, speech quality and emotional state using wearable devices (wristband, insoles) and a smartphone (with apps) for storing and transmitting the information. Control group participants will be asked to keep a symptom diary covering the same elements as PD_Manager records. After a minimum of two weeks, each participant will attend a consultation with a specialist doctor for review of the data gathered (by either means), and changes to management will be initiated as indicated. Patients, carers and clinicians will be asked for feedback on the acceptability and utility of the data collection methods. The PD_Manager intervention, compared to a symptom diary, will be evaluated in a cost-consequences framework. DISCUSSION: Information gathered will inform further development of the PD_Manager system and a larger effectiveness trial. TRIAL REGISTRATION: ISRCTN Registry, ISRCTN17396879 . Registered on 15 March 2017

Other Advanced Research Initiatives in Elderly Care and Fragility Prevention

Based on the lessons learnt from the co-design, development and integration processes, the research findings and the outputs from the engagement with a network of stakeholders over the course of the EU funded initiatives, this chapter will aim to help sketching the future policies and research funding programmes for ageing well in Europe. The chapter presents the visions and the perspectives of the running projects in the frame of the H2020 Personalized Medicine-15 call

An optional European contract law code: Advantages and disadvantages

Contract law, European union, Legal federalism, Regulatory competition,

Wettbewerbsföderalismus als Integrationskonzept für die Europäische Union

How can European integration be made compatible with maintaining decentrality and variety within Europe? This paper argues that both aims can only be achieved simultaneously by applying the concept of competitive federalism to the EU. After showing that interjurisdictional competition is a logical consequence of the removal of mobility barriers within the EU, basic tenets of the theory of a multi-level system of competing jurisdictions are presented. As a consequence, the EU has to provide an institutional framework for the proper working of interjurisdictional competition. In the second half of the paper, consequences of the application of competitive federalism to the EU are examined, e.g. the possibility that also many public goods and regulations might be provided competitively by lower-level jurisdictions. Finally, the problem of regulatory competition vs. harmonization is discussed, leading on to exploring advantages and problems of decentralised legal systems (legal federalism). Copyright Verein für Socialpolitik und Blackwell Publishers Ltd, 2002